Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond
“Targeted therapy” or “precision medicine” is a therapeutic strategy launched over two decades ago. It relies on drugs that inhibit key molecular mechanisms/pathways or genetic/epigenetic alterations that promote different cancer hallmarks. Many clinical trials, sponsored by multinational drug compa...
Main Authors: | Andrea Nicolini, Paola Ferrari |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/2/466 |
Similar Items
-
New and Emerging Targeted Therapies for Advanced Breast Cancer
by: Kristie H. Lau, et al.
Published: (2022-02-01) -
Advances in Cardiovascular Toxicity Associated with Targeted Therapy for Breast Cancer
by: WANG Yan, et al.
Published: (2021-05-01) -
Fulvestrant in the treatment of hormone receptor‐positive/human epidermal growth factor receptor 2‐negative advanced breast cancer: A review
by: Junjie Li, et al.
Published: (2019-05-01) -
Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate
by: Md Abdus Subhan, et al.
Published: (2023-04-01) -
Roles and mechanisms of aberrant alternative splicing in melanoma — implications for targeted therapy and immunotherapy resistance
by: Wanxian Chen, et al.
Published: (2024-03-01)